Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OUTBACK: BMS with BMAC for Talar Osteochondral Lesions
NCT04475341Unknown
- Sponsor
- University of Amsterdam
- Start
- Sep 2020
- Primary completion
- Sep 2024
- Modality
- Stem Cell Therapies
01
Overview
Randomised, double-blind trial of autologous bone marrow cell concentrate in osteochondral lesion of the talus (OLT) (2 arms), sponsored by University of Amsterdam. Primary endpoint: Numeric Rating Scale of Pain During Weightbearing at 2 years. Status: unknown.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
osteochondral lesion of the talus (OLT)
Beyond the preview
Go deeper on NCT04475341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04475341.